We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App




Improved CO2 Insufflator Assists Virtual Colonoscopy

By HospiMedica International staff writers
Posted on 09 Dec 2008
A new carbon dioxide (CO2) insufflator used in the early detection and diagnosis of colorectal cancer via a computerized tomography (CT) virtual colonoscopy offers improved safety and higher patient comfort.

The Vimap CO2 insufflator allows automatic or manual insufflation modes for high-risk patients, with an automatic regulated progression that maintains continuous insufflation. More...
The maximum insufflation velocity can be adjusted from one to three liters per minute. CO2 pressure is adjustable from 5 to 25 mm Hg in automatic mode and up to 35 mm Hg in manual mode, and is electronically controlled and relieved if it exceeds by just one mm Hg the preset pressure value. A regulator attached to the gas cylinder itself ensures a maximum entry pressure of one bar, while at the same time monitoring the level of CO2 left in the cylinder. The CO2 is delivered by the use of a single-use catheter that offers a smooth, comfortable, and automated colon insufflation. The Vimap CO2 insufflator is manufactured by GE Medical Systems (Cedex, France).

Virtual Colonoscopy is becoming increasingly accepted as a screening method for colorectal cancer, and in many settings, it is the technique of choice for complete examination of the colon after a failed or incomplete colonoscopy. In the past, physicians generally distended the colon using room air introduced with a handheld insufflation device, but CO2 is preferred, since it is readily absorbed by the bowel.

Related Links:
GE Medical Systems



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammography System (Analog)
MAM VENUS
LED Surgical Lamp
ACEMST35/57
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image:The biotechnology market in the GCC is projected to reach $2.6 billion by 2028, with the UAE and Saudi Arabia leading the growth in the region (Photo Courtesy of Infroma Markets)

WHX in Dubai (formerly Arab Health) to debut specialised Biotech & Life Sciences Zone as sector growth accelerates globally

World Health Expo (WHX) in Dubai, formerly Arab Health, which takes place from 9-12 February 2026 at the Dubai Exhibition Centre (DEC), has officially announced the launch of a new dedicated Biotech &... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.